ArticleACS medicinal chemistry letters2021

Discovery of a Highly Selective and Potent TRPC3 Inhibitor with High Metabolic Stability and Low Toxicity.

Sicheng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.